George Petrovas Net Worth 2026 Estimate and Sources

George Petrovas is a pharmaceutical industry executive and serial entrepreneur based in Newport, Rhode Island, with documented wealth creation through two company acquisitions by Magellan Health Services. No verified public net worth figure exists for him as of July 2026, but based on the available data points, a reasonable working estimate places his personal net worth somewhere in the range of $10 million to $30 million, with the real possibility of a higher figure if acquisition proceeds, restricted stock vesting, and real estate holdings are confirmed at full value. If you are looking for George Petrocheilos net worth specifically, the key takeaway is that public sources typically do not provide a confirmed figure for individuals in this profile. That range is an informed estimate, not a confirmed number, and the sections below explain exactly where it comes from and how to pressure-test it.

Who George Petrovas is

Before taking any net worth number at face value, it helps to confirm you are looking at the right person. If you are specifically researching ari petrou net worth, the same caution applies: verify identity first before relying on any estimate. The most prominently documented George Petrovas in public records is a pharmaceutical rebate management executive with roughly 30 years of industry experience. He co-founded ICORE Healthcare, which was acquired by Magellan Health Services in 2006. He then co-founded CDMI, LLC (with his wife Susan Petrovas), a Newport, Rhode Island-based pharmacy and medical management company specializing in clinical consulting programs and drug rebate negotiation for managed care organizations. A Magellan Health Services media room release for its Apr. 1, 2014 acquisition of CDMI identifies George Petrovas as co-founder and executive vice president of CDMI and says he would serve with Magellan upon closing blank" rel="noopener noreferrer">CDMI, LLC (with his wife Susan Petrovas). blank" rel="noopener noreferrer">Magellan acquired CDMI in 2014, and at the time of that deal Petrovas held the title of co-founder and executive vice president. He subsequently became a Magellan employee before departing the company by early 2018. He currently serves as president and founder of MDMI, LLC, and describes himself as an active investor. One additional biographical detail that helps distinguish him from others sharing the name: he briefly played professional football in the Canadian Football League for the BC Lions before his business career.

It is worth noting that other people named George Petrovas appear in unrelated contexts across sports, law, and other industries. If you arrived here looking for a different George Petrovas, the pharmaceutical rebate executive with the ICORE, CDMI, and Magellan connection is the one with the most documented public financial footprint. Readers familiar with other Greek business figures on this site, including profiles adjacent to this one such as those for Con Petropoulos or George Petrocheilos, will recognize that the Greek diaspora produces a wide range of high-achieving entrepreneurs across industries beyond the more traditional shipping and entertainment sectors.

The headline net worth figure and what it covers

The honest answer is that no credible third-party outlet, financial database, or public filing has published a specific net worth estimate for this George Petrovas as of 2026. What does exist is enough documentary evidence to construct a reasonable range. Working from the available data, a conservative to moderate estimate of $10 million to $30 million reflects personal net worth, meaning total assets (cash, investments, real estate, business equity) minus known or likely liabilities. The upper end of that range could be substantially higher if the full value of two acquisition payouts, restricted stock from Magellan, and the reported $16.1 million real estate purchase are all confirmed and largely unencumbered. The lower end reflects more conservative assumptions about deal structure, vesting conditions, taxes on gains, and the possibility that the real estate purchase involved significant mortgage financing.

This estimate focuses on personal fortune rather than business enterprise value. If you are specifically looking for Petrounias net worth, be aware that the underlying methodology can differ by person and by which assets are actually tied to the individual. MDMI, LLC is a privately held company and carries no publicly disclosed valuation. If MDMI were to be valued and added to the personal balance sheet, the number could shift meaningfully upward, but there is currently no basis for quantifying that.

How net worth estimates are actually built

Net worth estimates for private individuals like Petrovas are always reconstructed from indirect signals rather than a filed balance sheet. Here is how analysts typically approach someone with this kind of profile.

1. Acquisition proceeds: When a founder sells a company, the sale price and their ownership percentage determine the windfall. With two Magellan acquisitions (ICORE in 2006, CDMI in 2014), the question is what share of each deal Petrovas owned. Deal terms are rarely disclosed for private acquisitions, so analysts typically use the known sale price (if public) and apply a conservative ownership assumption of 20 to 50 percent for a co-founder, then subtract estimated taxes on the gain.
2. Equity compensation: SEC EDGAR filings reference Magellan restricted stock tied to Petrovas with vesting conditions linked to continued employment. The value depends on Magellan's stock price at vesting and the number of shares granted, neither of which is publicly disclosed in detail for his specific grant.
3. Real estate records: County property records and deed filings are public in most US states and provide a cost basis for real estate holdings. The San Diego Reader reported a $16.1 million estate purchase attributed to George Petrovas via Fairholme LLP. If confirmed in primary property records, that single asset materially anchors the lower bound of total wealth.
4. Business income: As president of MDMI, LLC, Petrovas likely draws a salary or owner's distribution. Without filed financials (private companies do not file public accounts), this stream is estimated based on industry norms for a pharmaceutical consulting firm of comparable size.
5. Investment portfolio: The MIT Entrepreneurship profile describes Petrovas as an active investor. Investment portfolios are private unless disclosed voluntarily, but the presence of a qualified annuity trust (the 'Petrovas Qualified Annuity Trust - 2011' referenced in Magellan acquisition documents) suggests formal wealth structuring and meaningful investable assets at least as of 2011 to 2014.

Income streams worth tracking

Understanding ongoing income is just as important as the historical wealth-creation events. For Petrovas, the plausible income streams in 2026 break down like this.

• MDMI, LLC operating income: As president and founder of a pharmaceutical consulting and drug rebate management firm, Petrovas likely receives a combination of salary and profit distributions. Comparable privately held healthcare consultancies in the managed care space generate revenues in the low-to-mid millions annually, with owner compensation potentially ranging from $300,000 to $1 million or more depending on scale.
• Investment returns: The active investor description and the presence of a structured annuity trust suggest a portfolio generating dividends, capital gains, or interest income. At a net worth of $10 to $30 million, typical investment income at a 4 to 6 percent yield would represent $400,000 to $1.8 million annually.
• Advisory or consulting fees: Senior pharmaceutical executives with Petrovas's track record, including two successful exits, are routinely engaged as advisors or board members at healthcare companies, generating fees that can range from $50,000 to several hundred thousand dollars per engagement.
• Restricted stock from Magellan: Any unvested Magellan shares that matured during his employment would have converted to cash or publicly traded stock, representing a one-time income event rather than ongoing income.
• Endorsements: There is no public evidence of endorsement or brand partnership income for Petrovas. This line item, common for athlete or celebrity wealth profiles, does not appear applicable here.

Assets and holdings that shape the total picture

The most concrete asset data point in the public record is the reported purchase of the Fairholme Cliff Walk estate in Newport, Rhode Island, for $16.1 million, attributed to Fairholme LLP managed by George N. Petrovas. Newport luxury real estate tends to hold or appreciate in value, so if that purchase is confirmed and the property is retained, it represents a substantial share of the estimated net worth range on its own. Newport has historically been a destination for high-net-worth Greek-American families, a pattern visible across the broader diaspora business community.

Beyond real estate, the likely asset categories include: equity or ownership stake in MDMI, LLC (unquantified but present), a personal investment portfolio (suggested by the annuity trust structure), and potentially retained Magellan Health stock if shares received as acquisition consideration were not fully liquidated. The 'Petrovas Qualified Annuity Trust - 2011' is a meaningful signal that professional wealth management was in place well before the CDMI acquisition closed in 2014, implying a layered asset structure rather than a single concentrated holding.

Liabilities and risks that can reduce net worth

Several factors could push the real number below even the conservative estimate.

• Litigation costs and outcomes: Petrovas was named as a defendant in a 2012 case involving Magellan Health Services and CDMI. The 11th Circuit case (19-13247) also describes a post-Magellan dispute involving restrictive covenants after he started a new rebate management company. Legal proceedings can result in settlements, damages, or legal fees that meaningfully erode personal wealth, particularly in commercial disputes involving non-compete enforcement.
• Real estate debt: If the $16.1 million property purchase was financed with a mortgage (common even among high-net-worth buyers for tax efficiency), the net equity in that asset could be substantially lower than the gross purchase price.
• Business liabilities: MDMI, LLC as a private company could carry operating debts, lease obligations, or contingent liabilities not visible in public records.
• Tax obligations on acquisition proceeds: Sale of a private company generally triggers capital gains tax at the federal level and potentially at the state level in Rhode Island. Large acquisition proceeds would have created a significant tax liability at the time of each deal, reducing the net cash available.
• Market exposure: An active investor with a meaningful portfolio faces the same volatility risks as any other investor. A concentrated position in healthcare equities, for example, would have experienced significant swings over the 2020 to 2026 period.

How to verify or update this estimate

Because no authoritative third-party source has published a confirmed figure, anyone who needs a more precise number should work from primary sources. Here is where to look and what to trust.

The most practical cross-check is Newport County property records, which are publicly searchable online and would confirm or deny the $16.1 million real estate data point. That single confirmation would establish a meaningful floor for total wealth. Separately, if MDMI, LLC files any registration documents, contract disclosures, or becomes involved in a publicly reported transaction, those events would update the picture materially.

Any estimate for George Petrovas that was published before 2018 (the year he left Magellan) should be treated as outdated, since his income structure and asset base likely changed significantly after that transition. The estimate in this article reflects conditions as of mid-2026 and should itself be revisited if a new acquisition, public role, or credible reporting emerges. Readers following similar Greek-American business figures, including executives profiled elsewhere on this site such as Akis Petretzikis or Elias Petrounias, will recognize that private entrepreneurs in this category rarely have confirmed public wealth figures until a major liquidity event or public disclosure forces one. If you are looking specifically for Akis Petretzikis net worth, the same approach and caution apply due to the lack of confirmed public figures.